In a world where medical breakthroughs often center around well-known diseases, a quiet revolution is underway in a lesser-known but life-threatening space—the Hemophagocytic Lymphohistiocytosis Treatment Market (HLH). Once overlooked due to its rarity and diagnostic challenges, HLH is now in the spotlight thanks to increased awareness, research advancements, and targeted...